Regular or frequent use of analgesics and acute antimigraine drugs can increase the
frequency of headache, and induce the transition from episodic to chronic headache or …

Medication overuse in primary headache disorders is a worldwide phenomenon and has a
role in the chronification of headache disorders. The burden of disease on individuals and …

Medication overuse headache is estimated to affect 2% of the population, and is ranked in
the top 20 most disabling disorders due to its high level of disability. Several therapies used …

Medication-overuse headache is defined as headache occurring on more than 15days in a
month in people with pre-existing primary headache, and developing as a consequence of …

Background Medication overuse is a significant issue that complicates the treatment of
headache disorders. The most effective medications for the acute treatment of migraine all …

Objective Medication-overuse headache (MOH) has been described for almost 100 years
and is characterized as a daily or near-daily headache that usually presents in patients with …

Background Anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies have
emerged as promising therapeutic options for the treatment of chronic migraine. However …

The available data indicate that anti-CGRP mAbs represent a good mechanism-based and
disease-specific therapeutical option with for MOH as long as detoxification and additional …

Background. Medication‐overuse headache (MOH) is a type of chronic headache, whose
mechanisms are still unknown. The impact of psychological factors has been matter of …

Medication overuse headache (MOH) is a secondary headache disorder attributed to
overuse of acute headache medications by a person with an underlying headache disorder …